<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="203425">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00441194</url>
  </required_header>
  <id_info>
    <org_study_id>HSOCT001</org_study_id>
    <nct_id>NCT00441194</nct_id>
  </id_info>
  <brief_title>To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series</brief_title>
  <official_title>To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series With Respect to Reliability, Reproducibility, Test Duration, Patient Preference, Technician Preference.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haag Streit USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haag Streit USA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the Octopus 311 and the HFA 700 series
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the Octopus 311 and the HFA 700 series to evaluate reliability, reproducibility,
      test duration, patient preference and technician preference.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study terminated due to resources
  </why_stopped>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">May 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Visual Field</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Visual Field (Octopus 311 and the HFA 700 series)</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prior Visual Field

        Exclusion Criteria:

          -  Scotopic pupil less than 3 mm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Powers, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>American, Virginia and Northern Virginia Optometric Associations</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Capital Eye Consultants</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <lastchanged_date>March 2, 2012</lastchanged_date>
  <firstreceived_date>February 27, 2007</firstreceived_date>
  <keyword>Perimetry</keyword>
  <keyword>Visual Field</keyword>
  <keyword>Octopus</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
